SMTL ID : 3hqw.1

Discovery of novel inhibitors of PDE10A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.111, H.145, D.146, D.256 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.111, A:H.145, A:D.146, A:D.256, H2O.22

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: D.146 Ligands: ZN.1 4 PLIP interactions: 1 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:D.146, H2O.17, H2O.21, H2O.22

1 x PF4: 4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole(Non-covalent)

PF4.3: 15 residues within 4Å: Chain A: V.260, I.274, Y.275, F.278, P.294, M.295, K.300, E.303, V.304, G.307, Q.308, G.310, F.311, A.314, V.315 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.274, A:Y.275, A:F.278, A:P.294, A:E.303, A:F.311, A:F.311, A:F.311 Hydrogen bonds: A:Q.308

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Verhoest, P.R. et al., Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia. J.Med.Chem. (2009)

Release Date

2009-08-04

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A